Sotera Health (NASDAQ:SHC) Price Target Cut to $12.00 by Analysts at Barclays

Sotera Health (NASDAQ:SHC) had its price objective cut by Barclays from $16.00 to $12.00 in a research note published on Thursday,Benzinga reports. They currently have an overweight rating on the stock.

Sotera Health Stock Down 0.8 %

Shares of SHC stock opened at $10.51 on Thursday. Sotera Health has a one year low of $9.53 and a one year high of $17.08. The company has a debt-to-equity ratio of 4.91, a current ratio of 2.88 and a quick ratio of 2.61. The stock has a fifty day moving average price of $12.15 and a 200 day moving average price of $13.52. The stock has a market cap of $2.98 billion, a P/E ratio of 42.04 and a beta of 1.88.

Institutional Trading of Sotera Health

Several institutional investors have recently made changes to their positions in SHC. Geode Capital Management LLC lifted its stake in Sotera Health by 19.4% during the third quarter. Geode Capital Management LLC now owns 2,755,391 shares of the company’s stock worth $46,026,000 after purchasing an additional 447,186 shares during the period. Neo Ivy Capital Management bought a new position in shares of Sotera Health during the 3rd quarter worth approximately $720,000. Barclays PLC boosted its stake in Sotera Health by 169.8% in the 3rd quarter. Barclays PLC now owns 473,597 shares of the company’s stock valued at $7,909,000 after buying an additional 298,085 shares in the last quarter. SG Americas Securities LLC grew its position in Sotera Health by 271.6% in the fourth quarter. SG Americas Securities LLC now owns 36,364 shares of the company’s stock valued at $497,000 after acquiring an additional 26,577 shares during the period. Finally, KBC Group NV raised its stake in Sotera Health by 4,094.6% during the fourth quarter. KBC Group NV now owns 186,365 shares of the company’s stock worth $2,549,000 after acquiring an additional 181,922 shares in the last quarter. 91.03% of the stock is currently owned by institutional investors and hedge funds.

About Sotera Health

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.